Steve Roffler
15Patents
5h-index
23Co-inventors
66Inventor score
Filing activity: Sep 30, 1998 → Nov 27, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6617118B2 | Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules | Physics | 16 | Expired |
| US6699972B1 | Chimeric protein and method of controlling tumor growth using the protein | Chemistry; Metallurgy | 11 | Expired |
| US6596849B1 | Monoclonal-antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules | Physics | 8 | Expired |
| US6043367A | Proactive antitumor compounds | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8491891B2 | Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such | Emerging Cross-Sectional Technologies | 7 | Active |
| US7320791B2 | Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules | Physics | 2 | Expired |
| US8507207B2 | Recombinant nucleotide sequence, cell or vector containing the same and method for using cell containing the same to encode anti-polyethylene glycol monoclonal antibodies | Performing Operations; Transporting | 1 | Active |
| US10532097B2 | Multi-drug delivery system and use thereof | Human Necessities | 1 | Active |
| US9458243B2 | Secondary antibody detected epitope and preparation of same | Physics | 0 | Active |
| US10180433B2 | Method for detecting protein by using secondary antibody detected epitope tag | Physics | 0 | Active |
| US11013690B2 | Esterification/saponification-based method for liposomal encapsulation of hydrophilic glucuronides | Human Necessities | 0 | Active |
| US9353140B2 | BQC-G, a tumor-selective anti-cancer prodrug | Human Necessities | 0 | Active |
| US10995126B2 | Immunogenic peptide containing a b cell epitope of tumor associated antigen L6 | Chemistry; Metallurgy | 0 | Active |
| US10604747B2 | Engineered enzyme for enzyme replacement therapy | Human Necessities | 0 | Active |
| US10912832B2 | Multi-drug delivery system and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.